skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Precision radiotherapy for cancer of the pancreas: technique and results. [Photons and electrons]

Conference · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
OSTI ID:6880416

Forty patients with locally extensive, unresectable adenocarcinoma of the pancreas received precision high dose (PHD) radiation therapy with a 45 MeV betatron. PHD radiotherapy was generally well tolerated. During treatment, only 7 patients experienced significant nausea, vomiting, diarrhea or anorexia. Late gastrointestinal radiation reactions were observed in 7 patients. Twelve patients received adjuvant chemotherapy. The projected survival of patients with unresectable pancreatic cancer treated with PHD radiotherapy is comparable to that of patients with resectable disease operated on for cure. The projected one year survival rate is 49%.

Research Organization:
Thomas Jefferson Univ. Hospital, Philadelphia, PA
OSTI ID:
6880416
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 6:9; Conference: 20. annual meeting of the American Society of Therapeutic Radiologists, Los Angeles, CA, USA, 1 Nov 1978
Country of Publication:
United States
Language:
English

Similar Records

Phase I Study of Daily Irinotecan as a Radiation Sensitizer for Locally Advanced Pancreatic Cancer
Journal Article · Tue Jun 01 00:00:00 EDT 2010 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:6880416

A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer
Journal Article · Sat Dec 01 00:00:00 EST 2012 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:6880416

Phase I Study of Conformal Radiotherapy and Concurrent Full-Dose Gemcitabine With Erlotinib for Unresected Pancreatic Cancer
Journal Article · Wed Feb 01 00:00:00 EST 2012 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:6880416